PURE Bioscience Share Price OTC Bulletin Board
Equities
US74621T2096
Household Products
Sales 2022 | 18.53L 15Cr | Sales 2023 | 18.77L 16Cr | Capitalization | 95.08L 79Cr |
---|---|---|---|---|---|
Net income 2022 | -30L -25Cr | Net income 2023 | -30L -25Cr | EV / Sales 2022 | 10.2 x |
Net cash position 2022 | 33.91L 28Cr | Net cash position 2023 | 74T 61.78L | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.08
x | P/E ratio 2023 |
-2.39
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.55% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/23/08 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 01/04/01 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 01/98/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/23/08 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09/11/09 |
Tom Lee
BRD | Director/Board Member | 75 | 24/14/24 |
1st Jan change | Capi. | |
---|---|---|
+11.51% | 2.58TCr | |
-6.34% | 1.66TCr | |
-15.86% | 691.44Cr | |
+2.65% | 578.93Cr | |
-8.87% | 295.27Cr | |
-2.71% | 216.53Cr | |
-0.11% | 210.01Cr | |
+19.54% | 89Cr | |
+5.80% | 66Cr |